{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T17:19:08Z","timestamp":1720372748206},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jviromet.2015.04.030","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T12:52:52Z","timestamp":1430830372000},"page":"95-99","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High-risk HPV detection and genotyping by APTIMA HPV using cervical samples"],"prefix":"10.1016","volume":"221","author":[{"given":"Michael T.","family":"Pyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille L.","family":"Hamula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schlaberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jviromet.2015.04.030_bib0010","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.27636","article-title":"The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy","volume":"132","author":"Arbyn","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/path.4424","article-title":"Are twenty human papillomavirus types causing cervical cancer?","author":"Arbyn","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0020","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ejca.2011.10.010","article-title":"Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study","volume":"48","author":"Carozzi","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2013.12.001","article-title":"Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: influence of assay target, cut off and age","volume":"59","author":"Cuschieri","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0040","series-title":"Hybrid Capture 2 High-Risk HPV DNA Test: Product Insert. L00665 Rev. 2","author":"Digene Corporation","year":"2013"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Suppl 1","key":"10.1016\/j.jviromet.2015.04.030_bib0050","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JCM.05989-11","article-title":"Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests","volume":"50","author":"Gage","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0060","series-title":"Aptima HPV 16 18\/45 Genotype Assay: Product Insert. AW-10840 Rev. 001","author":"Gen-Probe Incorporated","year":"2013"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0065","series-title":"APTIMA HPV Assay: Product Insert. 503789 Rev. A","author":"Gen-Probe Incorporated","year":"2013"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2007.09.009","article-title":"Real-time Taqman PCR targeting 14 human papilloma virus types","volume":"40","author":"Lindh","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0085","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","volume":"49","author":"Mesher","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0b013e318280f3bc","article-title":"Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection","volume":"23","author":"Nieves","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as hybrid capture 2 assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0110","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0120","series-title":"Cobas HPV Test: Product Insert. Doc Rev. 1.0","author":"Roche Molecular Systems","year":"2011"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0125","series-title":"Linear Array HPV Genotyping Test: Product Insert. Doc Rev. 3.0","author":"Roche Molecular Systems","year":"2011"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jviromet.2015.04.030_bib0135","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2015.04.030_bib0140","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093415001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093415001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T17:54:42Z","timestamp":1537638882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093415001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":28,"alternative-id":["S0166093415001743"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2015.04.030","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-risk HPV detection and genotyping by APTIMA HPV using cervical samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2015.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}